Panagora Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75M | Buy |
296,546
+74,542
| +34% | +$692K | 0.01% | 418 |
|
|
2025
Q1 | $1.63M | Sell |
222,004
-215,733
| -49% | -$1.58M | 0.01% | 561 |
|
|
2024
Q4 | $3.74M | Buy |
437,737
+173,382
| +66% | +$1.48M | 0.02% | 398 |
|
|
2024
Q3 | $2.3M | Buy |
+264,355
| New | +$2.3M | 0.01% | 515 |
|
|
2023
Q1 | – | Sell |
-38,757
| Closed | -$109K | – | 1511 |
|
|
2022
Q4 | $109K | Buy |
38,757
+1,805
| +5% | +$5.07K | ﹤0.01% | 1410 |
|
|
2022
Q3 | $153K | Sell |
36,952
-47,127
| -56% | -$195K | ﹤0.01% | 1392 |
|
|
2022
Q2 | $338K | Sell |
84,079
-1,345
| -2% | -$5.41K | ﹤0.01% | 1280 |
|
|
2022
Q1 | $423K | Buy |
85,424
+55,346
| +184% | +$274K | ﹤0.01% | 1273 |
|
|
2021
Q4 | $210K | Buy |
+30,078
| New | +$210K | ﹤0.01% | 1477 |
|
|
2021
Q3 | – | Sell |
-1,378
| Closed | -$20K | – | 2167 |
|
|
2021
Q2 | $20K | Buy |
1,378
+1,016
| +281% | +$14.7K | ﹤0.01% | 2171 |
|
|
2021
Q1 | $6K | Hold |
362
| – | – | ﹤0.01% | 2550 |
|
|
2020
Q4 | $7K | Sell |
362
-721
| -67% | -$13.9K | ﹤0.01% | 2382 |
|
|
2020
Q3 | $8K | Sell |
1,083
-1,118
| -51% | -$8.26K | ﹤0.01% | 2356 |
|
|
2020
Q2 | $18K | Hold |
2,201
| – | – | ﹤0.01% | 2158 |
|
|
2020
Q1 | $11K | Sell |
2,201
-16,774
| -88% | -$83.8K | ﹤0.01% | 2126 |
|
|
2019
Q4 | $75K | Buy |
+18,975
| New | +$75K | ﹤0.01% | 1856 |
|
|
2016
Q2 | – | Sell |
-3,100
| Closed | -$30K | – | 2332 |
|
|
2016
Q1 | $30K | Buy |
+3,100
| New | +$30K | ﹤0.01% | 2091 |
|